This month, DFC’s Chief Operating Officer David Marchick and other senior officials traveled to South Africa and India to advance the agency’s investments in the global health sector and bolster COVID-19 vaccine manufacturing capacity.
Access to safe and effective vaccines is an imperative for ending the global pandemic. Under President Biden’s leadership, DFC is targeting support for vaccines in developing countries, and the agency’s investments are projected to produce nearly 2 billion COVID-19 vaccine doses by the end of 2022. By advancing work in the vaccine sector, DFC aims to lead the global vaccination effort and save lives across the developing world.
DFC joined U.S. Chargé d’Affaires Todd Haskell and local leaders for a tour of Aspen Pharmacare’s sterile vaccine manufacturing facility in support of the agency’s partnership with the manufacturer.
Building Regional Vaccine Capacity in the Indo Pacific
DFC and Biological E. Limited announced the expansion of Biological E.’s vaccine manufacturing facility in Hyderabad, which will advance President Biden’s Quad Vaccine Partnership and accelerate the end of the pandemic.
The agency experienced a landmark fiscal year, catalyzing its largest level of financial commitments in a single year in 25 years and driving a five-fold growth in global health investments.
DFC’s visit to a data center operated by Africa Data Centres in Johannesburg highlighted the agency’s efforts to advance investments in information and communications technology across the continent.
In collaboration with HDFC Bank, Mastercard, and USAID, DFC launched a $100 million credit facility to unlock access to finance and encourage digitization for small businesses in India.
Chief Development Officer Andy Herscowitz joined the Energy Impact Podcast to discuss how DFC is increasing global access to reliable, clean, and affordable power.
